6541.TW | Tanvex BioPharma, Inc. Annual & Quarterly

Annual Balance Sheets

(In TWD)

Breakdown	2023	2022	2021	2020	2019	2018
Total Assets	2.76 Billion	3.41 Billion	4.71 Billion	4.37 Billion	3.57 Billion	4.47 Billion
Total Current Assets	604.21 Million	1.04 Billion	2.4 Billion	2.26 Billion	2.6 Billion	3.69 Billion
Cash And Short Term Investments	380.75 Million	786.23 Million	2.22 Billion	2.06 Billion	2.42 Billion	1.63 Billion
Cash and Cash Equivalents	380.75 Million	786.23 Million	2.22 Billion	2.06 Billion	2.42 Billion	1.63 Billion
Short Term Investments	-	-	-	-	-	1.89 Billion
Net Receivables	10.35 Million	2.75 Million	2.88 Million	1.9 Million	1.29 Million	140.46 Million
Inventory	108.28 Million	170.84 Million	90.33 Million	50.08 Million	52.2 Million	28.57 Million
Other Current Assets	104.81 Million	86.64 Million	85.79 Million	142.91 Million	124.03 Million	1.89 Billion
Total Non-Current Assets	2.15 Billion	2.37 Billion	2.31 Billion	2.1 Billion	968.01 Million	782.44 Million
Net PPE	1.92 Billion	2.15 Billion	2.11 Billion	1.9 Billion	922.96 Million	735.55 Million
Good Will And Intangible Assets	3.38 Million	12.06 Million	10.16 Million	11.95 Million	15.93 Million	18.16 Million
Good Will	-	-	-	-	-	-
Intangible Assets	3.38 Million	12.06 Million	10.16 Million	11.95 Million	15.93 Million	18.16 Million
Long-Term Investments	201.48 Million	203.56 Million	180.05 Million	182.71 Million	-	-
Tax Assets	-	-203.56 Million	-180.05 Million	-182.71 Million	-	-
Other Non Current Assets	26.18 Million	213.46 Million	187.58 Million	190.97 Million	29.12 Million	28.72 Million
Other Assets	-	-	-	-	-	-
Total Liabilities	1.94 Billion	2.02 Billion	1.91 Billion	1.75 Billion	542.12 Million	263.91 Million
Total Current Liabilities	363.73 Million	303.28 Million	248.51 Million	353.09 Million	270.44 Million	209.46 Million
Account Payables	-	-28.06 Million	-	-	-	-
Tax Payables	-	-	-	-	-	-
Short Term Debt	163.44 Million	124.65 Million	88.74 Million	65.73 Million	71.06 Million	7.27 Million
Deferred Revenue	6.9 Million	28.06 Million	-	-	-	-
Other Current Liabilities	193.37 Million	178.63 Million	159.76 Million	287.36 Million	199.38 Million	202.18 Million
Total Non Current Liabilities	1.57 Billion	1.72 Billion	1.67 Billion	1.39 Billion	271.67 Million	54.45 Million
Long-Term Debt	1.56 Billion	1.71 Billion	1.67 Billion	1.39 Billion	271.67 Million	-
Deferred Revenue Non Current	10.23 Million	-	-	-	-	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	1.56 Billion	10.46 Million	-	-	-	54.45 Million
Other Liabilities	1.00	-	-	-	-	-
Total Equity	821.11 Million	1.39 Billion	2.79 Billion	2.62 Billion	3.03 Billion	4.21 Billion
Stock Holders Equity	821.11 Million	1.39 Billion	2.79 Billion	2.62 Billion	3.03 Billion	4.21 Billion
Common Stock	1.33 Billion	3.52 Billion	3.52 Billion	3.11 Billion	2.64 Billion	2.43 Billion
Retained Earnings	-12.75 Billion	-12.96 Billion	-11.32 Billion	-9.78 Billion	-7.67 Billion	-5.38 Billion
Accumulated other comprehensive income	949.02 Million	592.45 Million	363.95 Million	344.61 Million	355.58 Million	239.04 Million
Common Stock Equity	821.11 Million	1.39 Billion	2.79 Billion	2.62 Billion	3.03 Billion	4.21 Billion
Capital Lease Obligation	1.56 Billion	1.83 Billion	1.75 Billion	1.42 Billion	342.74 Million	54.45 Million
Total Investments	201.48 Million	203.56 Million	180.05 Million	182.71 Million	-	1.89 Billion
Total Debt	1.73 Billion	1.83 Billion	1.75 Billion	1.46 Billion	342.74 Million	61.73 Million
Net Debt	1.35 Billion	1.05 Billion	-463.95 Million	-603.96 Million	-2.08 Billion	-1.56 Billion

Breakdown	2024 Q2	2024 Q1	2023 FY	2023 Q4	2023 Q3	2023 Q2
Total Assets	3.38 Billion	2.76 Billion	2.76 Billion	2.76 Billion	3.44 Billion	3.74 Billion
Total Current Assets	1.21 Billion	562.85 Million	604.21 Million	604.21 Million	1.13 Billion	1.48 Billion
Cash And Short Term Investments	1.04 Billion	385.23 Million	380.75 Million	380.75 Million	873.78 Million	1.21 Billion
Cash and Cash Equivalents	910.32 Million	385.23 Million	380.75 Million	380.75 Million	873.78 Million	1.21 Billion
Short Term Investments	130.28 Million	-	-	-	-	-
Net Receivables	19.66 Million	8.45 Million	10.35 Million	10.35 Million	870 Thousand	11.51 Million
Inventory	106.67 Million	111.18 Million	108.28 Million	108.28 Million	133.11 Million	141.9 Million
Other Current Assets	52.37 Million	57.97 Million	104.81 Million	104.81 Million	124.93 Million	110.03 Million
Total Non-Current Assets	2.16 Billion	2.2 Billion	2.15 Billion	2.15 Billion	2.31 Billion	2.25 Billion
Net PPE	1.92 Billion	1.96 Billion	1.92 Billion	1.92 Billion	2.05 Billion	2.03 Billion
Good Will And Intangible Assets	4.75 Million	5.03 Million	3.38 Million	3.38 Million	12.8 Million	12.08 Million
Good Will	-	-	-	-	-	-
Intangible Assets	4.75 Million	5.03 Million	3.38 Million	3.38 Million	12.8 Million	12.08 Million
Long-Term Investments	213.82 Million	210.14 Million	201.48 Million	201.48 Million	211.78 Million	204.1 Million
Tax Assets	-	-	-	-	-211.78 Million	-204.1 Million
Other Non Current Assets	24.16 Million	26.17 Million	26.18 Million	26.18 Million	238.17 Million	214.47 Million
Other Assets	-	-	-	-	-	-
Total Liabilities	1.91 Billion	2.35 Billion	1.94 Billion	1.94 Billion	2.07 Billion	1.95 Billion
Total Current Liabilities	335.25 Million	760.39 Million	363.73 Million	363.73 Million	378.56 Million	287.65 Million
Account Payables	-	-	-	-	-6.34 Million	-
Tax Payables	-	-	-	-	-	-
Short Term Debt	171.16 Million	542.15 Million	163.44 Million	163.44 Million	166.44 Million	150.53 Million
Deferred Revenue	21.99 Million	14.24 Million	6.9 Million	6.9 Million	6.34 Million	-
Other Current Liabilities	142.1 Million	203.99 Million	193.37 Million	193.37 Million	212.12 Million	137.11 Million
Total Non Current Liabilities	1.57 Billion	1.59 Billion	1.57 Billion	1.57 Billion	1.69 Billion	1.66 Billion
Long-Term Debt	1.56 Billion	1.58 Billion	1.56 Billion	1.56 Billion	1.68 Billion	1.66 Billion
Deferred Revenue Non Current	8.14 Million	9.33 Million	10.23 Million	10.23 Million	10.75 Million	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	8.14 Million	1.58 Billion	1.56 Billion	1.56 Billion	10.75 Million	-
Other Liabilities	-	-	1.00	1.00	-	-
Total Equity	1.47 Billion	405.9 Million	821.11 Million	821.11 Million	1.37 Billion	1.79 Billion
Stock Holders Equity	1.47 Billion	405.9 Million	821.11 Million	821.11 Million	1.37 Billion	1.79 Billion
Common Stock	1.64 Billion	1.34 Billion	1.33 Billion	1.33 Billion	1.33 Billion	1.33 Billion
Retained Earnings	-13.53 Billion	-13.17 Billion	-12.75 Billion	-12.75 Billion	-12.23 Billion	-11.73 Billion
Accumulated other comprehensive income	952.22 Million	949.14 Million	949.02 Million	949.02 Million	985.59 Million	908.88 Million
Common Stock Equity	1.47 Billion	405.9 Million	821.11 Million	821.11 Million	1.37 Billion	1.79 Billion
Capital Lease Obligation	1.56 Billion	1.58 Billion	1.56 Billion	1.56 Billion	1.84 Billion	1.81 Billion
Total Investments	344.1 Million	210.14 Million	201.48 Million	201.48 Million	211.78 Million	204.1 Million
Total Debt	1.73 Billion	2.13 Billion	1.73 Billion	1.73 Billion	1.84 Billion	1.81 Billion
Net Debt	827.81 Million	1.74 Billion	1.35 Billion	1.35 Billion	975.87 Million	594.46 Million

Balance Sheet Charts

Yalla Group Limited

YALA

Full Analysis

Annual Balance Sheets
CyberLink Corp.

5203

Full Analysis

Annual Balance Sheets
Skanska AB (publ)

SKBSY

Full Analysis

Annual Balance Sheets
Saul Centers, Inc.

BFS-PD

Full Analysis

Annual Balance Sheets
EnviroGold Global Limited

NVRO

Full Analysis

Annual Balance Sheets
Hunan Kaimeite Gases Co., Ltd.

002549

Full Analysis

Annual Balance Sheets

Global Stocks Search

Tanvex BioPharma, Inc. (6541.TW)

Annual Balance Sheets

Balance Sheet Charts

Yalla Group Limited

CyberLink Corp.

Skanska AB (publ)

Saul Centers, Inc.

EnviroGold Global Limited

Hunan Kaimeite Gases Co., Ltd.